Bioverativ's P2P Acquisition

Bioverativ raised a round of funding on March 08, 2018. Investors include Sanofi.

Bioverativ is a biopharmaceutical company focused on treatments for hemophilia and other rare blood disorders.…

Articles about Bioverativ's P2P Acquisition: